Feis Lawrence
SEC CIK 1535069 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REVB | REVELATION BIOSCIENCES, INC. | 10% | 0 | — | — | 1 | 2022-01-10 | 2022-01-10 |
Most active insiders at REVB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zygmont Chester Stanley III | CFO | — | — |
| 2 | Rolke James | CEO, Dir | — | — |
| 3 | CARVER JENNIFER | Dir | — | — |
| 4 | Chawla Lakhmir S | Dir | — | — |
| 5 | ROPER JESS | Dir | — | — |
Feis Lawrence made no open-market trades at REVB in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-01-11 | 2022-01-10 | REVB | REVELATION BIOSCIENCES, INC. | Feis Lawrence | 10% | J - Other | $10.20 | -732.0K | 0 | -100% | -$7.47M |
Purchase Sale Sale after option exercise All abbreviations